Ying Pan

3.8k total citations
65 papers, 3.3k citations indexed

About

Ying Pan is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Ying Pan has authored 65 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Epidemiology. Recurrent topics in Ying Pan's work include Diet, Metabolism, and Disease (15 papers), Liver Disease Diagnosis and Treatment (13 papers) and Stress Responses and Cortisol (12 papers). Ying Pan is often cited by papers focused on Diet, Metabolism, and Disease (15 papers), Liver Disease Diagnosis and Treatment (13 papers) and Stress Responses and Cortisol (12 papers). Ying Pan collaborates with scholars based in China, Czechia and Hong Kong. Ying Pan's co-authors include Ling‐Dong Kong, Qingyu Zhang, Yucheng Li, Xu-Yang Chen, Fu‐Meng Wang, Chuang Wang, Xing Xia, Li‐Tao Yi, Qun Xu and Qinghua Hu and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Journal of Neurochemistry.

In The Last Decade

Ying Pan

63 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Pan China 31 1.4k 614 559 435 385 65 3.3k
Shiping Ma China 43 1.4k 1.0× 855 1.4× 513 0.9× 571 1.3× 263 0.7× 89 4.2k
Perla D. Maldonado Mexico 34 1.3k 0.9× 554 0.9× 355 0.6× 291 0.7× 115 0.3× 72 3.7k
Mangala Lahkar India 32 792 0.6× 527 0.9× 279 0.5× 322 0.7× 231 0.6× 93 2.8k
Weizu Li China 31 1.1k 0.8× 270 0.4× 227 0.4× 159 0.4× 130 0.3× 88 2.3k
Li‐Tao Yi China 35 1.1k 0.8× 895 1.5× 483 0.9× 528 1.2× 136 0.4× 98 3.1k
Shifeng Chu China 38 1.9k 1.4× 330 0.5× 567 1.0× 147 0.3× 110 0.3× 128 3.9k
Tourandokht Baluchnejadmojarad Iran 44 1.2k 0.9× 242 0.4× 490 0.9× 102 0.2× 553 1.4× 174 4.2k
Weiwei Tao China 34 1.5k 1.1× 597 1.0× 574 1.0× 318 0.7× 85 0.2× 117 3.2k
Jin‐Fang Ge China 33 1.1k 0.8× 459 0.7× 119 0.2× 310 0.7× 261 0.7× 89 2.8k
Siu‐Po Ip Hong Kong 42 1.6k 1.2× 484 0.8× 1.1k 2.0× 326 0.7× 211 0.5× 117 4.3k

Countries citing papers authored by Ying Pan

Since Specialization
Citations

This map shows the geographic impact of Ying Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Pan more than expected).

Fields of papers citing papers by Ying Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Pan. The network helps show where Ying Pan may publish in the future.

Co-authorship network of co-authors of Ying Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Pan. A scholar is included among the top collaborators of Ying Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Pan. Ying Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Hong, Hongyu Jin, Wenyang Li, et al.. (2025). Adjuvant immunotherapy improves survival in completely resected stage IB–III NSCLC: a systematic review and meta-analysis. Frontiers in Oncology. 15. 1493221–1493221.
2.
Wu, Wen‐Yuan, Xiaoqin Ding, Tingting Gu, et al.. (2021). Correction to Pterostilbene Improves Hepatic Lipid Accumulation via the MiR-34a/Sirt1/SREBP-1 Pathway in Fructose-Fed Rats. Journal of Agricultural and Food Chemistry. 69(35). 10405–10405. 2 indexed citations
3.
Chen, Li, Yali Tang, Zhihong Liu, et al.. (2021). Atractylodin inhibits fructose-induced human podocyte hypermotility via anti-oxidant to down-regulate TRPC6/p-CaMK4 signaling. European Journal of Pharmacology. 913. 174616–174616. 8 indexed citations
4.
Pan, Ying, et al.. (2021). Thioredoxin interacting protein drives astrocytic glucose hypometabolism in corticosterone‐induced depressive state. Journal of Neurochemistry. 161(1). 84–100. 13 indexed citations
5.
Wu, Wen‐Yuan, Xiaoqin Ding, Ting-Ting Gu, et al.. (2020). Pterostilbene Improves Hepatic Lipid Accumulation via the MiR-34a/Sirt1/SREBP-1 Pathway in Fructose-Fed Rats. Journal of Agricultural and Food Chemistry. 68(5). 1436–1446. 25 indexed citations
6.
Zhao, Xiaojuan, Li Chen, Yue Zhao, et al.. (2019). Polygonum cuspidatum extract attenuates fructose-induced liver lipid accumulation through inhibiting Keap1 and activating Nrf2 antioxidant pathway. Phytomedicine. 63. 152986–152986. 26 indexed citations
7.
Li, Tushuai, Li Chen, Yan‐Zi Yang, et al.. (2019). Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1. Biochemical Pharmacology. 166. 139–152. 27 indexed citations
8.
9.
Jiang, Wei, et al.. (2018). 海洋真菌 Aspergillus niger XJJ-3中萘并吡喃酮类化合物结构及生物活性. 45(9). 1897–1903. 1 indexed citations
10.
Zhao, Xiaojuan, Yan‐Zi Yang, Yan-Jing Zheng, et al.. (2018). Dataset on assessment of magnesium isoglycyrrhizinate injection for dairy diet and body weight in fructose-induced metabolic syndrome of rats. Data in Brief. 18. 69–75. 1 indexed citations
11.
Jia, Keke, Hong Ding, Jiahui Liu, et al.. (2018). Chaihu-shugan san inhibits inflammatory response to improve insulin signaling in liver and prefrontal cortex of CUMS rats with glucose intolerance. Biomedicine & Pharmacotherapy. 103. 1415–1428. 43 indexed citations
12.
Li, Fuchao, et al.. (2016). miR-27b inhibits gastric cancer metastasis by targeting NR2F2. Protein & Cell. 8(2). 114–122. 45 indexed citations
13.
Pan, Ying & Ling‐Dong Kong. (2016). Urate transporter URAT1 inhibitors: a patent review (2012 - 2015). Expert Opinion on Therapeutic Patents. 26(10). 1129–1138. 11 indexed citations
14.
Zhang, Xian, Jianhua Zhang, Xu-Yang Chen, et al.. (2015). Reactive Oxygen Species-Induced TXNIP Drives Fructose-Mediated Hepatic Inflammation and Lipid Accumulation Through NLRP3 Inflammasome Activation. Antioxidants and Redox Signaling. 22(10). 848–870. 208 indexed citations
15.
Wang, Wei, Chuang Wang, Xiaoqin Ding, et al.. (2013). Quercetin and allopurinol reduce liver thioredoxin‐interacting protein to alleviate inflammation and lipid accumulation in diabetic rats. British Journal of Pharmacology. 169(6). 1352–1371. 161 indexed citations
16.
Ding, Xiaoqin, Ying Pan, Xing Wang, Yuxiang Ma, & Ling‐Dong Kong. (2013). Wuling San ameliorates urate under-excretion and renal dysfunction in hyperuricemic mice. Chinese Journal of Natural Medicines. 11(3). 214–221. 27 indexed citations
17.
Ju, Wang, Ying Pan, Ye Hong, et al.. (2012). Quercetin Protects against Cadmium-Induced Renal Uric Acid Transport System Alteration and Lipid Metabolism Disorder in Rats. Evidence-based Complementary and Alternative Medicine. 2012. 1–14. 28 indexed citations
18.
Wang, Hao, Jiang Li, Yang Gao, et al.. (2010). Xeno-oestrogens and phyto-oestrogens are alternative ligands for the androgen receptor. Asian Journal of Andrology. 12(4). 535–547. 43 indexed citations
19.
Xia, Xing‐Hua, et al.. (2006). Behavioral, neurochemical and neuroendocrine effects of the ethanolic extract from Curcuma longa L. in the mouse forced swimming test. Journal of Ethnopharmacology. 110(2). 356–363. 104 indexed citations
20.
Zhu, Min‐Sheng, Yuhua Fan, Xiangyu Xu, et al.. (1998). Abnormal expression of inducible nitric oxide synthase in Duchenne muscular dystrophy muscles. Chinese Science Bulletin. 43(10). 860–863. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiping Ma Breakdown of academic impact, for papers by Perla D. Maldonado Breakdown of academic impact, for papers by Mangala Lahkar Breakdown of academic impact, for papers by Weizu Li Breakdown of academic impact, for papers by Li‐Tao Yi Breakdown of academic impact, for papers by Shifeng Chu Breakdown of academic impact, for papers by Tourandokht Baluchnejadmojarad Breakdown of academic impact, for papers by Weiwei Tao Breakdown of academic impact, for papers by Jin‐Fang Ge Breakdown of academic impact, for papers by Siu‐Po Ip
Rankless by CCL
2026